Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Mar 15, 2020; 12(3): 301-310
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.301
Published online Mar 15, 2020. doi: 10.4251/wjgo.v12.i3.301
Figure 4 Univariate Cox analysis to predict risk of disease progression.
Difference between the two survival curves was assessed by long rank test, the HR with 95%CI was calculated by the Cox regression model (HR = 7.203; 95%CI: 1.531–33.882; P = 0.012). PFS: Progression free survival; TNF-α: Tumor necrosis alpha.
- Citation: Ricci V, Granetto C, Falletta A, Paccagnella M, Abbona A, Fea E, Fabozzi T, Lo Nigro C, Merlano MC. Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib. World J Gastrointest Oncol 2020; 12(3): 301-310
- URL: https://www.wjgnet.com/1948-5204/full/v12/i3/301.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i3.301